title: Inoculation of dogs with a recombinant ACTH vaccine.
abstract: OBJECTIVE
  To determine whether inoculation of healthy dogs with a recombinant peptide containing 3 copies of ACTH would result in the production of antibodies against ACTH and whether this would affect pituitary-adrenocortical function.
  
  
  METHODS
  8 healthy dogs.
  
  
  METHODS
  A recombinant peptide consisting of 3 copies of ACTH fused to a T-helper cell epitope was produced in Escherichia coli. The protein was inoculated into 4 dogs at 4-week intervals (total of 3 inoculations/dog). Four control dogs received inoculations of PBS solution mixed with adjuvant. Blood samples were collected for determination of antibody titers against ACTH and for measurement of basal and ACTH-stimulated plasma cortisol concentrations.
  
  
  RESULTS
  Inoculation with the ACTH vaccine resulted in production of anti-ACTH antibodies in all 4 dogs. Titers were initially high but declined by 15 weeks after the initial inoculation. Basal cortisol concentrations were unaffected by inoculation with the ACTH vaccine. Plasma cortisol concentrations in response to ACTH stimulation were reduced at 12 weeks, but not at 15 weeks, after the first inoculation.
  
  
  CONCLUSIONS
  Inoculation of dogs with a recombinant ACTH vaccine resulted in the production of antibodies against the hormone. Anti-ACTH titers were initially high but were not sustained. The only detectable endocrine effect in treated dogs was a reduction in cortisol concentration in response to ACTH stimulation in 2 of 4 dogs at 12 weeks after the first inoculation. The effect of vaccine administration on the pituitary-adrenal system was subtle and transient.
authors.affiliation: Department of Anatomy, Physiology, and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849.
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Kemppainen
mesh_terms: D000308:Adrenocortical Hyperfunction / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D000704:Analysis of Variance; D000818:Animals; D000906:Antibodies / Q000097:blood; D004217:Distemper Virus, Canine / Q000235:genetics; D004283:Dog Diseases / Q000276:immunology* / Q000517:prevention & control*; D004285:Dogs; D004926:Escherichia coli; D005260:Female; D005822:Genetic Vectors / Q000235:genetics; D006854:Hydrocortisone / Q000097:blood; D007273:Injections, Intramuscular; D008297:Male; D009842:Oligopeptides / Q000235:genetics; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000494:pharmacology*; D014759:Viral Envelope Proteins / Q000235:genetics
chemical_list: D000906:Antibodies; D009842:Oligopeptides; C583458:Trp-Ser- His-Pro-Gln-Phe-Glu-Lys; D014614:Vaccines, Synthetic; D014759:Viral Envelope Proteins; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone